In a news release, the US Food and Drug Administration (FDA) announced that CooperVision, a division of Cooper Companies Inc, has complied with their request for a widen recall effort of their Avaira Toric contact lenses.
CooperVision initiated a recall of their Avaira Toric contact lenses in August, however faced pressure from the FDA because the agency believed that the company had not done enough to educate the public of the recall. The FDA has since announced that the company has come into compliance with their request.
FDA spokeswoman Morgan Liscinsky said, “CooperVision’s public communications are consistent with the agency’s expectations. The FDA will continue to monitor this recall’s effectiveness to ensure that the affect devices are removed from the marketplace and not used by consumers.”
Whether the move by CooperVision is based solely on the FDA request or was monetarily based, the company saw a stock decrease of almost $5 a share Monday, though the stock remains up 23 percent for the year, has not been commented on by either the FDA or the company.
As a Bellingham personal injury attorney, I’ve seen many similar recalls in the past and am glad that the appropriate steps have been taken to inform the public of this situation. If you’ve been injured through the use of a defective product, it may be in your best interests to contact a personal injury lawyer to learn more about the legal avenues open to you.